Cardiology - Percutaneous coronary intervention and drug-eluting stents

被引：4
|
作者：
Yang, YM [1 ]
Moussa, I
机构：
[1] Lenox Hill Hosp, New York, NY 10021 USA
[2] Columbia Univ, Med Ctr, Cardiovasc Res Fdn, New York, NY USA
来源：
CANADIAN MEDICAL ASSOCIATION JOURNAL | 2005年 / 172卷 / 03期
关键词：
D O I：
10.1503/cmaj.1040945
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：323 / 325
页数：3
相关论文
共 50 条
  • [21] Obesity is a protective factor for percutaneous coronary intervention with drug-eluting stents: The overweight paradox
    Hassani, SE
    Wolfram, R
    Xue, ZY
    Gevorkian, N
    Pichard, A
    Weissman, NJ
    Satler, LF
    Kent, KM
    Waksman, R
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 47 (04) : 46B - 46B
  • [22] Outcomes After Percutaneous Coronary Intervention of Ostial Lesions in the Era of Drug-Eluting Stents
    Freeman, Melanie
    Clark, David J.
    Andrianopoulos, Nick
    Duffy, Stephen J.
    Lim, Han S.
    Brennan, Angela
    Charter, Kerrie
    Shaw, James
    Horrigan, Mark
    Ajani, Andrew E.
    Sebastian, Martin
    Reid, Christopher M.
    Farouque, H. M. Omar
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2009, 73 (06) : 763 - 768
  • [23] Percutaneous coronary intervention using drug-eluting stents in pediatric heart transplant recipients
    Sachdeva, Ritu
    Seib, Paul M.
    Frazier, Elizabeth A.
    Sachdeva, Rajesh
    PEDIATRIC TRANSPLANTATION, 2009, 13 (08) : 1014 - 1019
  • [24] Primary Percutaneous Coronary Intervention With Drug-Eluting Stents Another Chapter in the Stent Controversy
    Bates, Eric R.
    CIRCULATION-CARDIOVASCULAR INTERVENTIONS, 2008, 1 (02) : 87 - 89
  • [25] Impact of ad hoc percutaneous coronary intervention with drug-eluting stents in angina patients
    Kim, Young-Hak
    Park, Duk-Woo
    Ahn, Jung-Min
    Park, Gyung-Min
    Cho, Yong-Rak
    Lee, Jong-Young
    Kim, Won-Jang
    Yun, Sung-Cheol
    Kang, Soo-Jin
    Lee, Seung-Whan
    Lee, Cheol Whan
    Park, Seong-Wook
    Park, Seung-Jung
    EUROINTERVENTION, 2013, 9 (01) : 110 - 117
  • [26] Compliance With Dual Antiplatelet Therapy Following Percutaneous Coronary Intervention With Drug-Eluting Stents
    de Sa, Daniel D. Correa
    Lennon, Ryan J.
    Bresnahan, John F.
    Rihal, Charanjit S.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2009, 53 (10) : A371 - A371
  • [27] Balancing efficacy and safety of drug-eluting stents in patients undergoing percutaneous coronary intervention
    Jeremias, Allen
    Kirtane, Ajay
    ANNALS OF INTERNAL MEDICINE, 2008, 148 (03) : 234 - 238
  • [28] Changes in the practice of percutaneous coronary intervention following the introduction of drug-eluting stents.
    Shabari, FR
    Sadoughi, A
    Hashemi, V
    Pourdehmobed, K
    Farouque, HMO
    Ikeno, F
    Lyons, J
    Emami, S
    Kaneda, H
    Young, AC
    Rezaee, M
    AMERICAN JOURNAL OF CARDIOLOGY, 2004, 94 (6A): : 221E - 221E
  • [29] Percutaneous coronary intervention in patients with cancer using bare metal stents compared to drug-eluting stents
    Ahmed, Talha
    Pacha, Homam Moussa
    Addoumieh, Antoine
    Koutroumpakis, Efstratios
    Song, Juhee
    Charitakis, Konstantinos
    Boudoulas, Konstantinos Dean
    Cilingiroglu, Mehmet
    Marmagkiolis, Konstantinos
    Grines, Cindy
    Iliescu, Cezar A.
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2022, 9
  • [30] Percutaneous Coronary Interventions with Drug-Eluting Stent Implantation in Cases of Drug-Eluting Stents Restenosis
    Fettser, Denis
    Batyraliev, Talantbek
    Preobrazhensky, Dmitriy
    Sidorenko, Boris
    AMERICAN JOURNAL OF CARDIOLOGY, 2009, 103 (9A): : 18B - 19B
12345